Search - tctmd.com

Displaying 521 - 540 of 4251

Sort: Relevancy | Date

Presentation TVT 2016

The Reemergence of Transcarotid TAVR as a Worthwhile Alternative

Presenter: David J. Cohen

June 16, 2016

Presentation TVT 2016

The JenaValve TAVR System: Status Updates

Presenter: Hendrik Treede

June 16, 2016

Presentation TVT 2016

Study Design for the EVOLUT R Low-Risk Trial

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

Updates From the UK All-Comer TAVR Study

Presenter: Neil E. Moat

June 16, 2016

Presentation TVT 2016

Is Subclavian-Axillary TAVR the Preferred Alternative?

Presenter: A. Pieter Kappetein

June 16, 2016

Presentation TVT 2016

Updates From SURTAVI in Intermediate-Risk Patients

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

Advantages and Technique Recommendations for Direct Aortic Access for TAVR

Presenter: Vinayak Bapat

June 16, 2016

Presentation TVT 2016

Highlights From the SAPIEN 3 Experience in Intermediate-Risk Patients

Presenter: Vinod H. Thourani

June 16, 2016

Presentation TVT 2016

Transapical TAVR Remains a Worthwhile and Necessary Alternative: Results in a High-Volume Center and Optimal Technique

Presenter: Thomas Walther

June 16, 2016

Presentation TVT 2016

Updates From NOTION: The First All-Comer TAVR Trial

Presenter: Lars Sondergaard

June 16, 2016

Presentation TVT 2016

TVT 1075: Late Paravalvular Aortic Regurgitation: Migration of the Valve or Late Recoil?

Presenter: Ashkan Karimi, MD

June 16, 2016

Presentation TVT 2016

Be Prepared! The Management of Vascular Complications After Transfemoral TAVR

Presenter: James M. McCabe

June 16, 2016

Presentation TVT 2016

TVT 1125: Aortic Annulus Pseudoaneurysm Following Transcatheter Aortic Valve Implantation A Multimodality Approach to Define the Best Therapeutic Alternative

Presenter: Rogerio Sarmento-Leite, MD

June 16, 2016

Presentation TVT 2016

Step-by-Step: Vascular Screening, Transfemoral Access Techniques, and Percutaneous Closure After TAVR

Presenter: Jonathon M. White

June 16, 2016

Presentation TVT 2016

Highlights From PARTNER 2A in Intermediate-Risk Patients

Presenter: Michael J. Mack

June 16, 2016

Presentation TVT 2016

TVT 1074: Left Main Obstruction During TAVR With Lotus Valve

Presenter: Marek Grygier, MD

June 16, 2016

Presentation TVT 2016

The Current Practice of Risk Profiling and Patient Selection for TAVR in the EU: Evidence Based or Common Sense?

Presenter: Antonio Colombo

June 16, 2016

Presentation TVT 2016

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Thomas Walther

June 16, 2016

Presentation TVT 2016

A Practical Guide for the Treatment of Paravavular Regurgitation After TAVR

Presenter: Torsten P. Vahl

June 16, 2016

Presentation TVT 2016

TVT 1079: What Is This New Jet?! Acquired AortoRight Ventricular Fistula After Sapien 3 TAVR

Presenter: Hasan Ahmad, MD

June 16, 2016

Advertisement

The Reemergence of Transcarotid TAVR as a Worthwhile Alternative

The JenaValve TAVR System: Status Updates

Study Design for the EVOLUT R Low-Risk Trial

Updates From the UK All-Comer TAVR Study

Is Subclavian-Axillary TAVR the Preferred Alternative?

Updates From SURTAVI in Intermediate-Risk Patients

Advantages and Technique Recommendations for Direct Aortic Access for TAVR

Highlights From the SAPIEN 3 Experience in Intermediate-Risk Patients

Transapical TAVR Remains a Worthwhile and Necessary Alternative: Results in a High-Volume Center and Optimal Technique

Updates From NOTION: The First All-Comer TAVR Trial

TVT 1075: Late Paravalvular Aortic Regurgitation: Migration of the Valve or Late Recoil?

Be Prepared! The Management of Vascular Complications After Transfemoral TAVR

TVT 1125: Aortic Annulus Pseudoaneurysm Following Transcatheter Aortic Valve Implantation A Multimodality Approach to Define the Best Therapeutic Alternative

Step-by-Step: Vascular Screening, Transfemoral Access Techniques, and Percutaneous Closure After TAVR

Highlights From PARTNER 2A in Intermediate-Risk Patients

TVT 1074: Left Main Obstruction During TAVR With Lotus Valve

The Current Practice of Risk Profiling and Patient Selection for TAVR in the EU: Evidence Based or Common Sense?

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

A Practical Guide for the Treatment of Paravavular Regurgitation After TAVR

TVT 1079: What Is This New Jet?! Acquired AortoRight Ventricular Fistula After Sapien 3 TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content